Page last updated: 2024-09-03

mk 912 and 4-diphenylacetoxy-n-methylpiperidine methiodide

mk 912 has been researched along with 4-diphenylacetoxy-n-methylpiperidine methiodide in 1 studies

Compound Research Comparison

Studies
(mk 912)
Trials
(mk 912)
Recent Studies (post-2010)
(mk 912)
Studies
(4-diphenylacetoxy-n-methylpiperidine methiodide)
Trials
(4-diphenylacetoxy-n-methylpiperidine methiodide)
Recent Studies (post-2010) (4-diphenylacetoxy-n-methylpiperidine methiodide)
120827010

Protein Interaction Comparison

ProteinTaxonomymk 912 (IC50)4-diphenylacetoxy-n-methylpiperidine methiodide (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.055
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0009
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0005
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0045
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Other Studies

1 other study(ies) available for mk 912 and 4-diphenylacetoxy-n-methylpiperidine methiodide

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009